This month's issue provides new evidence related to the Medicare Advantage (MA) program, assesses Medicare’s value-based payment programs, examines options for improving care for patients with cancer, reveals the effects of
Medicaid expansion on state-level funding for substance use disorder (SUD) treatment, and more.
|